UMC revamps medicines safety cycle

Communications / 10 November 2022

By putting the patient front and centre, UMC is helping countries in the WHO Programme for International Drug Monitoring to promote the safer use of medicines globally.

UMC IS EXCITED TO announce the launch of a new communications resource to help explain the cycle of medicines safety.  

The PV Cycle, now live on UMC’s website in both English and Spanish, uses a visual narrative to take the reader through the different stages of the medicines safety cycle, with the patient at the centre of the story.

THE PV CYCLE WILL BE PROMOTED during #MedSafetyWeek by UMC and many of the participating PIDM member countries, who requested a more in-depth explanation of medicines safety to complement the other materials we produce. 

In our role at UMC we are often tasked with explaining why reporting side effects is important and what happens once a report is submitted. For this project we used an illustrated narrative to tell that story focusing on Lisa, a diabetic patient who experiences a side effect from her medication. Lisa’s doctor submits a report on the side effect, and we follow the report and the decisions that are made throughout – to protect patients from harm.

VISIT THE PV CYCLE PAGE on UMC’s website and keep an eye out for more content on UMC’s social media channels, as we bring Lisa’s story to the world, promoting medicines safety.

How medicines safety works –

Cómo funciona la seguridad de los medicamentos –


Matthew Barwick
Communications officer & video producer, UMC

You may also like

How to talk risk in a balanced way

Risks are not just numbers, but feelings. So how do you communicate risks accurately in a way that patients can interpret them? You give them facts, context, and trust.

Communications / 05 July 2022

“Living better lives”

UMC pays homage to a trailblazer in pharmacovigilance, Dr. Ed Napke

Communications / 14 March 2023

Peter Hjelmström joins UMC as new director

Uppsala Monitoring Centre (UMC), the WHO Collaborating Centre for International Drug Monitoring, is pleased to announce the arrival of its new director Peter Hjelmström.

Communications / 06 March 2023

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more